text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

PI3K Inhibitor

No.172(January 2017)
W0007
Wortmannin (1)
Autophagy is a catabolic process that digests components of the cytoplasm via lysosomes and is mediated by an organelle called the autophagosome.1,2) Autophagy is regulated by various serine/threonine protein kinases, such as mTOR, AKT, MARK etc.3) Phosphoinositide 3-kinases (PI3Ks) are also a class of such enzymes regulating autophagy. Especially, the class III PI3K promotes the formation of the autophagosome vesicle4) and a complex of the PI3K and beclin controls autophagy.5)
Wortmannin (1) is a potent PI3K inhibitor. Phosphatidylinositol 3,4,5-trisphosphate formation of fMLP-stimulated neutrophils is inhibited with a dose-responsive manner of 1 (IC50: 5 nM).6) It was shown that the treatment of rat hepatocytes with 1 inhibits autophagy with an IC50 of 30 nM.7)
It has been known that the properties of induced pluripotent stem cells (iPSCs), self-renewing and differentiation, make these cells tumorigenic.8) Zouboulis et al. reported that 1 can rapidly induce apoptosis in iPSCs.9) They discussed about apoptotic elimination of remaining undifferentiated iPSCs using 1 in their article.
mTOR: mammalian target of rapamycin
AKT: from the name of AKT8 retrovirus (J. Exp. Med. 1988, 167, 1259.)
MARK: mitogen-activated protein kinase
fMLP: N-formyl-L-methionyl-L-leucyl-L-phenylalanine
The product is for research purpose only.

References

Related Compounds

M2410
LY294002
I0975
PluriSIn 1
The prices are subject to change without notice. Please confirm the newest price by our online catalog before placing an order.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.
Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.